Abstract

The present study aimed to assess the association between sedentary behavior and sarcopenia among adults aged ≥65 years. Cross-sectional data from the Study on Global Ageing and Adult Health were analyzed. Sarcopenia was defined as having low skeletal muscle mass and either a slow gait speed or a weak handgrip strength. Self-reported sedentary behavior was assessed as a continuous variable (hours per day) and also as a categorical variable (0–<4, 4–<8, 8–<11, ≥11 hours/day). Multivariable logistic regression was conducted to assess the association between sedentary behavior and sarcopenia. Analyses using the overall sample and country-wise samples were conducted. A total of 14,585 participants aged ≥65 years were included in the analysis. Their mean age was 72.6 (standard deviation, 11.5) years and 55% were females. Compared to sedentary behavior of 0–<4 hours/day, ≥11 hours/day was significantly associated with 2.14 (95% CI = 1.06–4.33) times higher odds for sarcopenia. The country-wise analysis showed that overall, a one-hour increase in sedentary behavior per day was associated with 1.06 (95% CI = 1.04–1.10) times higher odds for sarcopenia, while the level of between-country heterogeneity was low (I2 = 12.9%). Public health and healthcare practitioners may wish to target reductions in sedentary behavior to aid in the prevention of sarcopenia in older adults.

Highlights

  • Sarcopenia may be defined as “age-related muscle loss, affecting a combination of appendicular muscle mass, muscle strength, and/or physical performance measures” [1]

  • The prevalence of sarcopenia was 15.7%, while the percentage of those who engaged in 0–

  • The country-wise analysis showed that overall, a one-hour increase in sedentary behavior per day is associated with a 1.06 times higher odds for sarcopenia, and the level of between-country heterogeneity was low (I2 = 12.9%) (Figure 2)

Read more

Summary

Introduction

Sarcopenia may be defined as “age-related muscle loss, affecting a combination of appendicular muscle mass, muscle strength, and/or physical performance measures” [1]. The prevalence of sarcopenia is high in older adults. A recent meta-analysis suggested that sarcopenia prevalence in older adults is approximately 10% [2]. Sarcopenia has been shown to be associated with several adverse health outcomes in older people. In a recent umbrella review with integrated meta-analyses on the association between sarcopenia with other medical conditions in older adults, it was found that sarcopenia was associated with premature mortality, disability, and falls [3]. Other research has suggested that sarcopenia is associated with a significantly higher proportion of problems relating to several dimensions of quality of life [4]. Owing to the relatively high prevalence of sarcopenia and the associated adverse health outcomes, research is needed to identify modifiable risk factors of the condition to inform targeted interventions

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.